Floatz logo

Fuzuloparib

Childhood Obesity

University of South CarolinaPhase 1/2Active
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Childhood Obesity cohort.

Asset / SponsorPhaseRating
Docosahexaenoic Acid
University of Milan
Phase 4BBB
Immunofos
University of Milan
Phase 4BB
Zeprumetostat
University of South Carolina
Phase 1/2CCC
PREDNISONE TABLETS
University of Colorado, Denver
N/AD
INTERFERON ALFA-2B
University of Colorado, Denver
N/AD

Same molecule, other indications

Fuzuloparib is also rated in:

Obese Patients With Prostate Cancer DiseaseDormant
B
Indicative ·
60 / 100
View asset →
Chronic Postsurgical PainDormant
B
Indicative ·
60 / 100
View asset →
triple-negative breast carcinomaDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →